Low dose rifaximin combined with N-acetylcysteine is superior to rifaximin alone in a rat model of IBS-D: a randomized trial
Gabriela Leite(Universidade Federal Rural do Semi-Árido), Maya Pimentel(Cedars-Sinai Medical Center), Ruchi Mathur(Cedars-Sinai Medical Center), Gillian M. Barlow, Maritza Sanchez(Cedars-Sinai Medical Center), Ali Rezaie(Cedars-Sinai Medical Center), Mark Pimentel(Cedars-Sinai Medical Center), Sarah Ayyad, María Jesús Villanueva-Millán, Juliana de Freitas Germano, Walter Morales, Stacy Weitsman, Gonzalo Parodi
Cited by 4
Related Papers
Methanogens and Hydrogen Sulfide Producing Bacteria Guide Distinct Gut Microbe Profiles and Irritable Bowel Syndrome Subtypes
|The American Journal of Gastroenterology|2022|158
Age and the aging process significantly alter the small bowel microbiome
|Cell Reports|2021|155
Quantitative sequencing clarifies the role of disruptor taxa, oral microbiota, and strict anaerobes in the human small-intestine microbiome
|Microbiome|2021|92
Defining Small Intestinal Bacterial Overgrowth by Culture and High Throughput Sequencing
|Clinical Gastroenterology and Hepatology|2023|77